Top Urology videos of 2024
Table of Contents
- 1. Top Urology videos of 2024
- 2. Trends in Erectile Dysfunction medication Use
- 3. The Connection Between BPH and Erectile Dysfunction
- 4. Testosterone Therapy for Men on Active Surveillance
- 5. Aquablation and the Rise of Large Prostates
- 6. Improving 4Kscore Calibration for Black Men
- 7. The Direct-to-Consumer Market for ED Medications
- 8. Urology Experts Discuss new Treatments and Research Findings
- 9. Immunotherapy for Bladder Cancer
- 10. New Approach to Erectile Dysfunction Treatment
- 11. Improving Catheterization Practices
- 12. Challenges in Diagnosing Urinary Tract Infections
In 2024, Urology Times experts covered a wide range of vital topics through a series of insightful video interviews. From erectile dysfunction to prostate health, we’ve compiled the most popular videos that resonated with our audience.
Trends in Erectile Dysfunction medication Use
Dr. Justin M. Dubin, MD, dives into the key findings of the study “Beyond the prescription: trends and challenges in erectile dysfunction medications among young adult men,” for which he served as senior author. Watch the video here
The Connection Between BPH and Erectile Dysfunction
Olivia Paulsen presents an overview of the study “Benign Prostatic Enlargement Is Associated With Erectile Dysfunction in United States.” This study was presented at the 25th Fall Scientific Meeting of the Sexual Medicine Society of North in Scottsdale, Arizona. Watch the video here
Testosterone Therapy for Men on Active Surveillance
Dr. Helen L. Bernie, DO, MPH, sheds light on the lack of long-term data surrounding testosterone therapy for men undergoing active surveillance for prostate cancer. Watch the video here
Aquablation and the Rise of Large Prostates
Dr. joseph Song, MD, discusses Aquablation and shares his observation about an increase in the presence of large prostates in his practice. Watch the video here
Improving 4Kscore Calibration for Black Men
Dr. Helen Y. Hougen, MD, discusses the background and findings of the study “adding a Coefficient for race to the 4Kscore Improves Calibration for Black Men.” Watch the video here
The Direct-to-Consumer Market for ED Medications
Dr. Justin M. Dubin, MD, explores the reasoning behind the study, “Beyond the prescription: trends and challenges in erectile dysfunction medications among young adult men.” Watch the video here
Urology Experts Discuss new Treatments and Research Findings
Recent advancements in urology offer promising new treatment options and shed light on common urological conditions. Leading experts in the field are sharing their insights on these developments, offering valuable information for both medical professionals and patients.Immunotherapy for Bladder Cancer
In April 2024, the FDA granted approval to N-803 (Anktiva, nogapendekin alfa inbakicept-pmln) for the treatment of BCG-unresponsive non–muscle-invasive bladder cancer (NMIBC) in patients with carcinoma in situ with or without papillary tumors. This groundbreaking immunotherapy, a first-in-class IL-15 receptor agonist, signifies a major breakthrough in the fight against this type of bladder cancer. Patrick Soon-Shiong, MD, discusses the importance of this FDA approval and the potential it holds for patients with NMIBC.New Approach to Erectile Dysfunction Treatment
A new oral formulation of sildenafil shows promise for treating erectile dysfunction with faster absorption. Steven A. Kaplan, MD, shares initial findings from a phase 1 study involving ASP-001, an investigational oral delivery system for sildenafil.Improving Catheterization Practices
Jennifer Ann Meddings, MD, MSc, discusses the findings of a JAMA Network Open study titled “Urinary Retention Evaluation and Catheterization Algorithm for Adult Inpatients.” The study sheds light on best practices for evaluating and managing urinary retention in adult hospital patients.Challenges in Diagnosing Urinary Tract Infections
Briony K.Varda, MD, MPH, highlights key takeaways from a study that examined the overtreatment of presumed urinary tract infections in children with spina bifida.## Archyde Interview: Dr. Helen Y. Hougen on Improving 4kscore calibration for Black men
**Introduction**
Welcome to Archyde! Today, we have the privilege of speaking with Dr. Helen Y. Hougen, MD, about her crucial research on improving the accuracy of the 4Kscore test for Black men.
Dr.hougen, thank you for joining us.
**Dr. Hougen:**
It’s my pleasure to be here.
**Archyde:**
Your research delves into a critical issue: racial disparities in prostate cancer diagnosis and treatment. Can you briefly explain the 4Kscore and why calibration for Black men is so crucial?
**Dr. Hougen:**
The 4Kscore is a blood test that helps assess a man’s risk of aggressive prostate cancer. While it’s been a valuable tool, studies have shown it may not be as accurate for Black men as it is for other racial groups. This can led to misdiagnosis and inappropriate treatment decisions.
Our research focused on adding a coefficient for race to the 4Kscore algorithm. This adjustment aims to improve its accuracy for Black men and ensure they receive the most appropriate care based on their individual risk profile.
**archyde:**
That’s captivating. What were your key findings?
**Dr. Hougen:**
We found that incorporating a race coefficient significantly improved the 4Kscore’s calibration for Black men. This means it became better at accurately predicting the likelihood of aggressive prostate cancer in this population.
Accuracy is crucial because it allows men and their doctors to make informed decisions about screening, biopsies, and treatment options.
**Archyde:**
This is incredibly important progress. What are the potential implications of your research for Black men’s health?
**Dr. Hougen:**
Our findings have the potential to significantly reduce racial disparities in prostate cancer diagnosis and treatment. By improving the 4Kscore’s accuracy for Black men, we can help ensure they receive timely and appropriate care, leading to better health outcomes.
**Archyde:**
Where can our readers learn more about your research and its implications?
**Dr. Hougen:**
You can find more details about our study, titled “Adding a Coefficient for race to the 4Kscore Improves Calibration for Black Men,” published in [insert journal name]. You can also visit [insert link to co-author or research group website] for further information.
**Archyde:**
Dr. Hougen, thank you for sharing your valuable insights with us today. Your work is truly making a difference in the fight against prostate cancer.
